Citations (19)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (1)
Thomas P. Thomopoulos, Anthi Bouhla, Sotirios G. Papageorgiou & Vasiliki Pappa. (2021) Chronic myelomonocytic leukemia - a review. Expert Review of Hematology 14:1, pages 59-77.
Read now
Read now
Articles from other publishers (18)
P. V. Lipilkin, E. D. Kulaeva, E. V. Ryabikina, E. V. Degtereva & Yu. V. Shatokhin. (2023) Some results of a pilot study of mutations in ASXL1 and DNMT3A genes in myelodysplastic syndrome. South Russian Journal of Therapeutic Practice 4:1, pages 97-105.
Crossref
Crossref
Ao Zhang, Shuxing Wang, Quanlei Ren, Yizhu Wang & Zhiping Jiang. (2022)
Prognostic value of
ASXL1
mutations in patients with myelodysplastic syndromes and acute myeloid leukemia: A meta‐analysis
. Asia-Pacific Journal of Clinical Oncology.
Crossref
Crossref
Ibolya Czegle, Austin L. Gray, Minjing Wang, Yan Liu, Jun Wang & Edina A. Wappler-Guzzetta. (2021) Mitochondria and Their Relationship with Common Genetic Abnormalities in Hematologic Malignancies. Life 11:12, pages 1351.
Crossref
Crossref
Iván Martín, Eva Villamón, Rosario Abellán, Maria José Calasanz, Aroa Irigoyen, Guillermo Sanz, Esperanza Such, Elvira Mora, Míriam Gutiérrez, Rosa Collado, Rocío García‐Serra, Míriam Vara, Mª Laura Blanco, Itziar Oiartzabal, Sara Álvarez, Teresa Bernal, Isabel Granada, Blanca Xicoy, Andrés Jerez, Marisa Calabuig, Rosana Diez, Ángela Gil, María Díez-Campelo, Carlos Solano & Mar Tormo. (2021)
Myelodysplastic syndromes with 20q deletion: incidence, prognostic value and impact on response to azacitidine of
ASXL1
chromosomal deletion and genetic mutations
. British Journal of Haematology 194:4, pages 708-717.
Crossref
Crossref
Gunnar Juliusson, Sören Lehmann & Vladimir Lazarevic. 2021. Acute Myeloid Leukemia. Acute Myeloid Leukemia
1
22
.
Cristina Panuzzo, Elisabetta Signorino, Chiara Calabrese, Muhammad Shahzad Ali, Jessica Petiti, Enrico Bracco & Daniela Cilloni. (2020) Landscape of Tumor Suppressor Mutations in Acute Myeloid Leukemia. Journal of Clinical Medicine 9:3, pages 802.
Crossref
Crossref
Sarah Charrot, Hannah Armes, Ana Rio‐Machin & Jude Fitzgibbon. (2019) AML through the prism of molecular genetics. British Journal of Haematology 188:1, pages 49-62.
Crossref
Crossref
Xinyue Huang & Xiaoxue Wang. (2020) Effect of enhancer of zeste homolog 2 mutations on the prognosis of patients with myelodysplastic syndrome. Medicine 99:34, pages e21900.
Crossref
Crossref
David M. Swoboda & David A. Sallman. (2019) Mutation-Driven Therapy in MDS. Current Hematologic Malignancy Reports 14:6, pages 550-560.
Crossref
Crossref
Shuhei Asada, Takeshi Fujino, Susumu Goyama & Toshio Kitamura. (2019) The role of ASXL1 in hematopoiesis and myeloid malignancies. Cellular and Molecular Life Sciences 76:13, pages 2511-2523.
Crossref
Crossref
Xiaoxue Wang, Xiaomeng Song & Xiaojing Yan. (2019) Effect of RNA splicing machinery gene mutations on prognosis of patients with MDS. Medicine 98:21, pages e15743.
Crossref
Crossref
Frank Griscelli, Christophe Desterke, Olivier Feraud, Dominique Divers, Noufissa Oudrhiri, Lucie Tosca, Ali G. Turhan & Annelise Bennaceur-Griscelli. (2019) Genomic landscape analyses of reprogrammed cells using integrative and non-integrative methods reveal variable cancer-associated alterations. Oncotarget 10:28, pages 2693-2708.
Crossref
Crossref
Sandrine Niyongere, Nolwenn Lucas, Jun-Min Zhou, Samer Sansil, Anthony D. Pomicter, Maria E. Balasis, John Robinson, Jodi Kroeger, Qing Zhang, Yu Long Zhao, Markus Ball, Rami Komrokji, Alan List, Michael W. Deininger, Brooke L. Fridley, Valeria Santini, Eric Solary & Eric Padron. (2018) Heterogeneous expression of cytokines accounts for clinical diversity and refines prognostication in CMML. Leukemia 33:1, pages 205-216.
Crossref
Crossref
SoJung An, Ui-Hyun Park, Seungtae Moon, Myengmo Kang, Hyesook Youn, Jin-Taek Hwang, Eun-Joo Kim & Soo-Jong Um. (2019) Asxl1 ablation in mouse embryonic stem cells impairs neural differentiation without affecting self-renewal. Biochemical and Biophysical Research Communications 508:3, pages 907-913.
Crossref
Crossref
Raphael Itzykson, Pierre Fenaux, David Bowen, Nicholas C.P. Cross, Jorge Cortes, Theo De Witte, Ulrich Germing, Francesco Onida, Eric Padron, Uwe Platzbecker, Valeria Santini, Guillermo F. Sanz, Eric Solary, Arjan Van de Loosdrecht & Luca Malcovati. (2018) Diagnosis and Treatment of Chronic Myelomonocytic Leukemias in Adults. HemaSphere 2:6, pages e150.
Crossref
Crossref
Shuhei Asada, Susumu Goyama, Daichi Inoue, Shiori Shikata, Reina Takeda, Tsuyoshi Fukushima, Taishi Yonezawa, Takeshi Fujino, Yasutaka Hayashi, Kimihito Cojin Kawabata, Tomofusa Fukuyama, Yosuke Tanaka, Akihiko Yokoyama, Satoshi Yamazaki, Hiroko Kozuka-Hata, Masaaki Oyama, Shinya Kojima, Masahito Kawazu, Hiroyuki Mano & Toshio Kitamura. (2018) Mutant ASXL1 cooperates with BAP1 to promote myeloid leukaemogenesis. Nature Communications 9:1.
Crossref
Crossref
Hye Sook Youn, Tae-Yoon Kim, Ui-Hyun Park, Seung-Tae Moon, So-Jung An, Yong-Kyu Lee, Jin-Taek Hwang, Eun-Joo Kim & Soo-Jong Um. (2017) Asxl1 deficiency in embryonic fibroblasts leads to cellular senescence via impairment of the AKT-E2F pathway and Ezh2 inactivation. Scientific Reports 7:1.
Crossref
Crossref
Li-Hong Shou, Dan Cao, Xiao-Hui Dong, Qiu Fang, Ying Wu, Yan Zhang, Ju-Ping Fei & Bao-Lian Xu. (2017) Prognostic significance of SETBP1 mutations in myelodysplastic syndromes, chronic myelomonocytic leukemia, and chronic neutrophilic leukemia: A meta-analysis. PLOS ONE 12:2, pages e0171608.
Crossref
Crossref